Does ACALABRUTINIB Cause Chronic obstructive pulmonary disease? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Chronic obstructive pulmonary disease have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 0.3% of all adverse event reports for ACALABRUTINIB.
24
Reports of Chronic obstructive pulmonary disease with ACALABRUTINIB
0.3%
of all ACALABRUTINIB reports
3
Deaths
13
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From ACALABRUTINIB?
Of the 24 reports, 3 (12.5%) resulted in death, 13 (54.2%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACALABRUTINIB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which ACALABRUTINIB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC